GlaxoSmithKline is the pharmaceutical company committed to facilitating access to medicines in developing countries, according to “Access to Medicine Index”.

Madrid, July 2010.- GlaxoSmithKline (GSK) has been singled out by the Access to Medicine Index ” as the pharmaceutical company, responsible and committed sector in humanitarian work by sending continuous medicines to countries in developing. This prestigious ranking, which analyzes the efforts of the leading companies in this sector, has been located at GSK in the first place in the ranking.

The authors of this report, the second carried out after the first edition published in 2008, have pointed out that the pharmaceutical industry has evolved in these two years in the number of initiatives in CSR. Thus, include areas such as research and development and more equitable and accessible pricing.

The co-founder of this ranking, Wim Leereveld, stressed the long way to go has the pharmaceutical industry in the world. For its part, Carissa Etienne, Assistant Director-general of the World Health Organization (WHO), has been added to the Access to Medicine Index ” in addition to assess industry individually promoted access to essential medicines.

In the 2010 edition of Access to Medicine Index ” highlights the fact that six of the ten companies with best score are European and four American.

The above ranking, which can be consulted on the website http://www.accesstomedicineindex.org, was created by the Dutch Foundation Access to Medicine ” in collaboration with the consultant RiksMetrics ”, specializing in corporate social responsibility (CSR).

GlaxoSmithKline – one of the leading companies in research-based pharmaceutical and health care is committed to the improvement of the quality of life of people doing that to live more and better.